1. Centres for Disease Control and Prevention. Spotlight - Advancing our Epidemiologic Understanding of Lupus http://www.cdc.gov/arthritis/resources/spotlights/advancing.htm
2. Assessment of patients with systemic lupus erythematosus and the use of lupus disease activity indices;Griffiths;Best Pract Res Clin Rheumatol,2005
3. Clinical trials for lupus - are we there yet?;Merrill;Bull NYU Hosp Jt Dis,2009
4. Efficacy and safety of rituximab in moderately-to-severely active systemic lupus erythematosus: the randomized, double-blind, phase II/III systemic lupus erythematosus evaluation of rituximab trial;Merrill;Arthritis Rheum,2010
5. Efficacy and safety of rituximab in patients with proliferative lupus nephritis: results from the randomized, double-blind phase III LUNAR study;Furie;Arthritis Rheum,2009